Clinical Trial Update: Pegfilgrastim vs. Filgrastim - Comparison of Mobilized Blood Stem Cells in Patients With Non Hodgkin-lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial comparing pegfilgrastim with filgrastim for mobilized blood stem cell collection in patients with non-Hodgkin lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Filgrastim (filgrastim)
• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Non-Hodgkin Lymphoma | Phase 2 | Status: COMPLETED